158 related articles for article (PubMed ID: 32068886)
1. Cell proliferation and neurogenesis alterations in Alzheimer's disease and diabetes mellitus mixed murine models.
Hierro-Bujalance C; Del Marco A; José Ramos-Rodríguez J; Infante-Garcia C; Bella Gomez-Santos S; Herrera M; Garcia-Alloza M
J Neurochem; 2020 Sep; 154(6):673-692. PubMed ID: 32068886
[TBL] [Abstract][Full Text] [Related]
2. Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer's disease and type 2 diabetes.
Infante-Garcia C; Ramos-Rodriguez JJ; Galindo-Gonzalez L; Garcia-Alloza M
Psychoneuroendocrinology; 2016 Mar; 65():15-25. PubMed ID: 26708068
[TBL] [Abstract][Full Text] [Related]
3. Central vascular disease and exacerbated pathology in a mixed model of type 2 diabetes and Alzheimer's disease.
Ramos-Rodriguez JJ; Jimenez-Palomares M; Murillo-Carretero MI; Infante-Garcia C; Berrocoso E; Hernandez-Pacho F; Lechuga-Sancho AM; Cozar-Castellano I; Garcia-Alloza M
Psychoneuroendocrinology; 2015 Dec; 62():69-79. PubMed ID: 26254770
[TBL] [Abstract][Full Text] [Related]
4. Liraglutide Reduces Vascular Damage, Neuronal Loss, and Cognitive Impairment in a Mixed Murine Model of Alzheimer's Disease and Type 2 Diabetes.
Carranza-Naval MJ; Del Marco A; Hierro-Bujalance C; Alves-Martinez P; Infante-Garcia C; Vargas-Soria M; Herrera M; Barba-Cordoba B; Atienza-Navarro I; Lubian-Lopez S; Garcia-Alloza M
Front Aging Neurosci; 2021; 13():741923. PubMed ID: 34975451
[TBL] [Abstract][Full Text] [Related]
5. Increased hippocampal neurogenesis in the progressive stage of Alzheimer's disease phenotype in an APP/PS1 double transgenic mouse model.
Yu Y; He J; Zhang Y; Luo H; Zhu S; Yang Y; Zhao T; Wu J; Huang Y; Kong J; Tan Q; Li XM
Hippocampus; 2009 Dec; 19(12):1247-53. PubMed ID: 19309037
[TBL] [Abstract][Full Text] [Related]
6. Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer's disease and type 2 diabetes.
Hierro-Bujalance C; Infante-Garcia C; Del Marco A; Herrera M; Carranza-Naval MJ; Suarez J; Alves-Martinez P; Lubian-Lopez S; Garcia-Alloza M
Alzheimers Res Ther; 2020 Apr; 12(1):40. PubMed ID: 32264944
[TBL] [Abstract][Full Text] [Related]
7. The db mutation improves memory in younger mice in a model of Alzheimer's disease.
Zhang L; Fernandez-Kim SO; Beckett TL; Niedowicz DM; Kohler K; Dasuri K; Bruce-Keller AJ; Murphy MP; Keller JN
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2157-2167. PubMed ID: 31034991
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer's Disease Stage in APP/PS1 Mice.
Ettcheto M; Petrov D; Pedrós I; Alva N; Carbonell T; Beas-Zarate C; Pallas M; Auladell C; Folch J; Camins A
J Alzheimers Dis; 2016 Jul; 54(1):233-51. PubMed ID: 27567882
[TBL] [Abstract][Full Text] [Related]
9. Progressive Neuronal Pathology and Synaptic Loss Induced by Prediabetes and Type 2 Diabetes in a Mouse Model of Alzheimer's Disease.
Ramos-Rodriguez JJ; Spires-Jones T; Pooler AM; Lechuga-Sancho AM; Bacskai BJ; Garcia-Alloza M
Mol Neurobiol; 2017 Jul; 54(5):3428-3438. PubMed ID: 27177549
[TBL] [Abstract][Full Text] [Related]
10. Amyloid beta and diabetic pathology cooperatively stimulate cytokine expression in an Alzheimer's mouse model.
Sankar SB; Infante-Garcia C; Weinstock LD; Ramos-Rodriguez JJ; Hierro-Bujalance C; Fernandez-Ponce C; Wood LB; Garcia-Alloza M
J Neuroinflammation; 2020 Jan; 17(1):38. PubMed ID: 31992349
[TBL] [Abstract][Full Text] [Related]
11. Effects of Cerebrolysin on neurogenesis in an APP transgenic model of Alzheimer's disease.
Rockenstein E; Mante M; Adame A; Crews L; Moessler H; Masliah E
Acta Neuropathol; 2007 Mar; 113(3):265-75. PubMed ID: 17131129
[TBL] [Abstract][Full Text] [Related]
12. Telomere shortening reduces Alzheimer's disease amyloid pathology in mice.
Rolyan H; Scheffold A; Heinrich A; Begus-Nahrmann Y; Langkopf BH; Hölter SM; Vogt-Weisenhorn DM; Liss B; Wurst W; Lie DC; Thal DR; Biber K; Rudolph KL
Brain; 2011 Jul; 134(Pt 7):2044-56. PubMed ID: 21672962
[TBL] [Abstract][Full Text] [Related]
13. Early Changes in Hippocampal Neurogenesis in Transgenic Mouse Models for Alzheimer's Disease.
Unger MS; Marschallinger J; Kaindl J; Höfling C; Rossner S; Heneka MT; Van der Linden A; Aigner L
Mol Neurobiol; 2016 Oct; 53(8):5796-806. PubMed ID: 27544234
[TBL] [Abstract][Full Text] [Related]
14. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
15. Environmental enrichment reverses Aβ pathology during pregnancy in a mouse model of Alzheimer's disease.
Ziegler-Waldkirch S; Marksteiner K; Stoll J; d'Errico P; Friesen M; Eiler D; Neudel L; Sturn V; Opper I; Datta M; Prinz M; Meyer-Luehmann M
Acta Neuropathol Commun; 2018 May; 6(1):44. PubMed ID: 29855361
[TBL] [Abstract][Full Text] [Related]
16. Increasing brain glucose uptake by Gypenoside LXXV ameliorates cognitive deficits in a mouse model of diabetic Alzheimer's disease.
Meng X; Zhang Y; Li Z; Ma G; Zhang X; Zhang D; Cao W; Wang S; Cai Q; Cui P; Huang G
Phytother Res; 2023 Feb; 37(2):611-626. PubMed ID: 36325883
[TBL] [Abstract][Full Text] [Related]
17. Regional comparison of the neurogenic effects of CNTF-derived peptides and cerebrolysin in AβPP transgenic mice.
Rockenstein E; Ubhi K; Doppler E; Novak P; Moessler H; Li B; Blanchard J; Grundke-Iqbal I; Iqbal K; Mante M; Adame A; Crews L; Masliah E
J Alzheimers Dis; 2011; 27(4):743-52. PubMed ID: 21860085
[TBL] [Abstract][Full Text] [Related]
18. Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease.
Zhang C; McNeil E; Dressler L; Siman R
Exp Neurol; 2007 Mar; 204(1):77-87. PubMed ID: 17070803
[TBL] [Abstract][Full Text] [Related]
19. Dual roles of Aβ in proliferative processes in an amyloidogenic model of Alzheimer's disease.
Baglietto-Vargas D; Sánchez-Mejias E; Navarro V; Jimenez S; Trujillo-Estrada L; Gómez-Arboledas A; Sánchez-Mico M; Sánchez-Varo R; Vizuete M; Dávila JC; García-Verdugo JM; Vitorica J; Gutierrez A
Sci Rep; 2017 Aug; 7(1):10085. PubMed ID: 28855626
[TBL] [Abstract][Full Text] [Related]
20. The age-related slow increase in amyloid pathology in APP.V717I mice activates microglia, but does not alter hippocampal neurogenesis.
Hoeijmakers L; Meerhoff GF; de Vries JW; Ruigrok SR; van Dam AM; van Leuven F; Korosi A; Lucassen PJ
Neurobiol Aging; 2018 Jan; 61():112-123. PubMed ID: 29059594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
